อาคารแพทยพัฒน์

Amidst the vibrant tapestry of Bangkok stands the Padtayapatana Building, a cornerstone of Chulalongkorn University. This unassuming structure, also known as อาคารแพทยพัฒน์, houses a center of groundbreaking research. Welcome to the home of the Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, or Chula PKPGx as it’s often called. In 2024, this center moved to its current location within the Mongkut Petcharat research building. The Padtayapatana Building itself is part of the larger medical faculty. So, while you won’t find historical tales of kings and queens here, you’ll discover stories of scientific exploration. The air hums with the energy of researchers tackling real-world medical challenges. They delve into the complex interactions between drugs and the human body. Their work ranges from studying how the body processes medication in elderly patients to optimizing drug dosages for children. One area of focus is on a group of enzymes known as CYP3A and drug transporters. These play a vital role in metabolizing drugs. The researchers at Chula PKPGx are investigating how these change in Thai elderly, with and without chronic kidney disease. They use something called a “microdose cocktail” in their research. Another fascinating project explores the pharmacokinetics of drugs like piperacillin and meropenem in children. They investigate how these antibiotics behave in young bodies, aiming to ensure safe and effective treatment. This research extends beyond simply understanding how the body processes drugs. The team also delves into pharmacogenomics. This field examines how a person’s genes affect their response to medications. Think of it as personalized medicine. By understanding an individual’s genetic makeup, doctors can tailor drug treatments for maximum effectiveness and minimal side effects. The Chula PKPGx center isn’t just a place of research. It’s a bridge between scientific discovery and real-world application. The findings made within these walls translate into improved patient care. They contribute to point-of-care services. This includes measuring drug and biomarker levels and providing pharmacogenetic testing. As you stand before the Padtayapatana Building, remember that you are at the forefront of medical innovation in Thailand. Here, dedicated researchers unravel the mysteries of drug interactions. They strive to create a healthier future, one personalized treatment at a time.